A new UniSC study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms of post-traumatic ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...